Efficacy of Dapagliflozin versus Empagliflozin on Glycemic Control and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus. (2026). World Journal of Current Medical and Pharmaceutical Research, 8(2), 185-189. https://doi.org/10.37022/wjcmpr.v8i2.415